Evidence map›Paper›PMID 25413828›Full record

Trial reportVirologica Sinica2014

Viral respiratory infections among Hajj pilgrims in 2013.

Osamah Barasheed, Harunor Rashid, Mohammad Alfelali, Mohamed Tashani, Mohammad Azeem, Hamid Bokhary, Nadeen Kalantan, Jamil Samkari, Leon Heron, Jen Kok and 9 more

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Virologica Sinica, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 6 pooled it
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 6 syntheses or guidelines pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Community pharmacists' knowledge, prospective and practice towards health related illness at Hajj and Umrah: A cross sectional study.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 10 institutions in 3 countries.

Osamah BarasheedNational Centre for Immunisation Research and Surveillance (NCIRS), The Children's Hospital at Westmead, Sydney, NSW, Australia, osamah.barasheed@health.nsw.gov.au.
Harunor Rashid
Mohammad Alfelali
Mohamed Tashani
Mohammad Azeem
Hamid Bokhary
Nadeen Kalantan
Jamil Samkari
Leon Heron
Jen Kok
Janette Taylor
Haitham El Bashir
Ziad A Memish
Elizabeth Haworth
Edward C Holmes
Dominic E Dwyer
Atif Asghar
Robert Booy
Hajj Research Team
National Centre for Immunisation Research & Surveillance · AUChildren's Hospital at Westmead · AUKing Abdulaziz University · SAThe University of Sydney · AUUmm al-Qura University · SAWestmead Hospital · AUHamad Medical Corporation · QAKing Abdulaziz Medical City · SAMenzies School of Health Research · AUMinistry of Health · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Middle East respiratory syndrome coronavirus (MERS-CoV) has emerged in the Arabian Gulf region, with its epicentre in Saudi Arabia, the host of the 'Hajj' which is the world's the largest mass gathering. Transmission of MERS-CoV at such an event could lead to its rapid worldwide dissemination. Therefore, we studied the frequency of viruses causing influenza-like illnesses (ILI) among participants in a randomised controlled trial at the Hajj 2013. We recruited 1038 pilgrims from Saudi Arabia, Australia and Qatar during the first day of Hajj and followed them closely for four days. A nasal swab was collected from each pilgrim who developed ILI. Respiratory viruses were detected using multiplex RT-PCR. ILI occurred in 112/1038 (11%) pilgrims. Their mean age was 35 years, 49 (44%) were male and 35 (31%) had received the influenza vaccine pre-Hajj. Forty two (38%) pilgrims had laboratory-confirmed viral infections; 28 (25%) rhinovirus, 5 (4%) influenza A, 2 (2%) adenovirus, 2 (2%) human coronavirus OC43/229E, 2 (2%) parainfluenza virus 3, 1 (1%) parainfluenza virus 1, and 2 (2%) dual infections. No MERS-CoV was detected in any sample. Rhinovirus was the commonest cause of ILI among Hajj pilgrims in 2013. Infection control and appropriate vaccination are necessary to prevent transmission of respiratory viruses at Hajj and other mass gatherings.

Indexed as

AdolescentAdultAgedFemaleHumansMaleMiddle AgedRespiratory Tract InfectionsSaudi ArabiaVirus DiseasesVirusesYoung Adult

Identifiers

PMID25413828
PMCPMC7090649
OpenAlexW1986025221

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.